Accuracy of PET/CT in the diagnosis of pelvic lymph node metastases in melanoma: A subgroup analysis of the prospective, randomised, phase III Evaluation of groin lymphadenectomy extent for metastatic melanoma (EAGLE-FM) trial
European Journal of Surgical Oncology · 2026
DOI: 10.1016/j.ejso.2025.111163 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift European Journal of Surgical Oncology, 2026. Verfasst von Michael Russell und 17 weiteren Autor:innen. Beteiligte Einrichtung: Melanoma Institute Australia, The University of Sydney, Sydney, Australia; Mater Hospital Sydney, Sydney, Australia; Royal North Shore Hospital, Sydn…. Hauptthemen laut MEDLINE: Melanoma, Positron Emission Tomography Computed Tomography, Lymph Node Excision, Lymph Nodes. Die Arbeit nennt 31 Literaturangaben. Gefördert von: Mater Foundation, Melanoma Institute Australia, Cancer Council New South Wales.
Abstract (Originalsprache)
BACKGROUND: PET/CT is widely used in the staging of patients with melanoma groin lymph node (LN) metastases. This study aims to utilise prospectively collected data to determine the accuracy of this modality in the diagnosis of pelvic metastases in those patients with known inguinal LN involvement. METHODS: Data collected as part of the Evaluation of Groin Lymphadenectomy Extent for Metastatic Melanoma (EAGLE-FM) trial was analysed. Patients with known inguinal LN metastases were evaluated with 18 F-FDG PET/CT. Those without evidence of pelvic LN abnormalities were randomised to inguinal dissection or ilio-inguinal dissection. Those with evidence of abnormality in the pelvic LNs were excluded from the main EAGLE-FM trial but offered ilio-inguinal dissection. Post operative histology results from those patients undergoing ilio-inguinal dissection were analysed to determine the accuracy of PET/CT in the assessment of pelvic LNs. RESULTS: There were 101 patients randomised on the EAGLE-FM trial. For this substudy, there were 49 patients who had negative pelvic LNs on PET/CT and 5 patients with positive pelvic nodes on PET/CT included in this analysis. The sensitivity of PET/CT was 25 %, specificity 95.6 % with positive predictive value (PPV) 50.0 % and negative predictive value (NPV) 87.8 %. CONCLUSION: PET/CT has reasonable NPV but poor PPV. While PET/CT is an important modality in the staging of patients with stage III melanoma, it has limited accuracy in the diagnosis of pelvic LN metastases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Melanoma Institute Australia, The University of Sydney, Sydney, Australia; Mater Hospital Sydney, Sydney, Australia; Royal North Shore Hospital, Sydney, Australia. Electronic address: michael.russell@waitematadhb.govt.n…
- Department of Theranostics and Nuclear Medicine, St Vincent's Hosptial, Sydney, NSW, Australia; St Vincent's Clinical School, University of New South Wales, Sydney, NSW, Australia; Garvan Institute of Medical Research,…
- Institute of Oncology Ljubljana, Medical Faculty, University of Ljubljana, Slovenia.
- Melanoma Institute Australia, The University of Sydney, Sydney, Australia; Mater Hospital Sydney, Sydney, Australia; Royal Prince Alfred Hospital, Sydney, Australia.
- Peter MacCallum Cancer Centre, Department of Surgical Oncology, Melbourne, Australia.
- Hospital de Cancer de Barretos, Brazil.
Förderung
- Mater Foundation
- Melanoma Institute Australia
- Cancer Council New South Wales
Zitieren
APA
Russell, M., Emmett, L., Peric, B., Saw, R. P., Spillane, J., Vasquez, V., Duprat, J., Moncrieff, M., Allan, C., van Leeuwen, B., Pritchard-Jones, R., Rastrelli, M., de Wilt, J., Bertolli, E., Sommariva, A., Geh, J., Howle, J., & Spillane, A. (2026). Accuracy of PET/CT in the diagnosis of pelvic lymph node metastases in melanoma: A subgroup analysis of the prospective, randomised, phase III Evaluation of groin lymphadenectomy extent for metastatic melanoma (EAGLE-FM) trial. European Journal of Surgical Oncology. https://doi.org/10.1016/j.ejso.2025.111163
Vancouver
Russell M, Emmett L, Peric B, Saw RP, Spillane J, Vasquez V, et al. Accuracy of PET/CT in the diagnosis of pelvic lymph node metastases in melanoma: A subgroup analysis of the prospective, randomised, phase III Evaluation of groin lymphadenectomy extent for metastatic melanoma (EAGLE-FM) trial. European Journal of Surgical Oncology. 2026. doi:10.1016/j.ejso.2025.111163
BibTeX
@article{Russell2026,
author = {Russell, Michael and Emmett, Louise and Peric, Barbara and Saw, Robyn Pm and Spillane, John and Vasquez, Vinicius and Duprat, Joao and Moncrieff, Marc and Allan, Chris and van Leeuwen, Barbara and Pritchard-Jones, Rowan and Rastrelli, Marco and de Wilt, Johannes and Bertolli, Eduardo and Sommariva, Antonio and Geh, Jenny and Howle, Julie and Spillane, Andrew},
title = {Accuracy of PET/CT in the diagnosis of pelvic lymph node metastases in melanoma: A subgroup analysis of the prospective, randomised, phase III Evaluation of groin lymphadenectomy extent for metastatic melanoma (EAGLE-FM) trial},
journal = {European Journal of Surgical Oncology},
year = {2026},
doi = {10.1016/j.ejso.2025.111163}
}
EUVIMED